# Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia

> **NCT00435370** · PHASE3 · COMPLETED · sponsor: **Baylor College of Medicine** · enrollment: 179 (actual)

## Conditions studied

- Smoking Cessation
- Schizophrenia

## Interventions

- **DRUG:** Tropisetron
- **DRUG:** Placebo
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00435370
- **Lead sponsor:** Baylor College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2011-02
- **Final completion:** 2011-08
- **Target enrollment:** 179 (ACTUAL)
- **Last updated:** 2017-03-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00435370

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00435370, "Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in Schizophrenia". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00435370. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*